|
Placebo-controlled phase 3 studies of antipsychotics in schizophrenia
P'al Czobor, Nathan Kline Institute for Psychiatric Research, United States
|
|
Legal and ethical considerations concerning research with mentally incapacitated patients
Sander PK Welie, University of Maastricht, Institute of Bioethics, The Netherlands
|
|
Formal and clinical assessment of mental capacity in psychiatry
Jochen Vollmann, University of Erlangen-Nuremberg, Germany
|
|
Ethical implications of relationships between psychiatrists and pharmaceutical industry
Prof Hanfried Helmchen, Free University of Berlin, Germany
|